pargyline has been researched along with Neoplasms in 4 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, B | 1 |
Liu, P | 1 |
Wu, H | 1 |
Xie, X | 1 |
Chen, Z | 1 |
Zeng, F | 1 |
Wu, S | 1 |
He, Y | 1 |
Zhao, Y | 1 |
Wang, L | 2 |
Bohrer, LR | 1 |
Pan, Y | 1 |
Huang, H | 1 |
Jeleń, M | 1 |
Pluta, K | 1 |
Zimecki, M | 1 |
Morak-Młodawska, B | 1 |
Artym, J | 1 |
Kocięba, M | 1 |
Kochanowska, I | 1 |
Zhu, W | 1 |
Lee, CY | 1 |
Johnson, RL | 1 |
Wichterman, J | 1 |
Huang, R | 1 |
DePamphilis, ML | 1 |
4 other studies available for pargyline and Neoplasms
Article | Year |
---|---|
A bioorthogonal nanosystem for imaging and in vivo tumor inhibition.
Topics: Animals; Antineoplastic Agents; Coumarins; Ferrous Compounds; Fluorescent Dyes; HeLa Cells; Humans; | 2017 |
LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation.
Topics: Animals; Camptothecin; Carcinogenesis; Cell Line, Tumor; Cellular Senescence; Chromatin; Demethylati | 2018 |
Synthesis and biological evaluation of novel propargylquinobenzothiazines and their derivatives as potential antiproliferative, anti-inflammatory, and anticancer agents.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Autoimmune Diseases; Cell Line, Tumo | 2016 |
An image-based, high-throughput screening assay for molecules that induce excess DNA replication in human cancer cells.
Topics: Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Proliferation; Disulfiram; DNA Replication | 2011 |